View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/SAMHSA RIN: 0930-AA33 Publication ID: Fall 2023 
Title: Mandatory Guidelines for Federal Workplace Drug Testing Programs--Hair 

This action proposes to establish the scientific and technical guidelines for the inclusion of hair specimens in the Mandatory Guidelines for Federal Workplace Drug Testing Programs and standards for certification of laboratories engaged in drug testing for federal agencies. SAMHSA has chosen to reissue these Guidelines as proposed rather than as final to seek further public comment on unresolved scientific issues related to external contamination and forensic hair testing for drugs, and on changes to align the HMG with the proposed final urine mandatory guidelines (UrMG) and oral fluid mandatory guidelines (OFMG).

Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: None     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: sec. 503 of Pub. L. 100-71    5 U.S.C. 7301    E.O. 12564   
Legal Deadline:  None
Action Date FR Cite
NPRM  09/10/2020  85 FR 56108   
NPRM Comment Period End  11/09/2020 
SNPRM  11/00/2023 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Ron Flegel
Director, Division of Workplace Programs, CSAP
Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
5600 Fishers Lane, Room 16N01,
Rockville, MD 20857
Phone:240 276-2611